Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus placebo for macular vessel density after phacoemulsification
IRCT20220216054042N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cataract comparing Ketorolac arm with Placebo arm (2 arms). Primary endpoints: Size of foveal avascular zone and Vascular density of the parafovea. Started May 2023; status: completed.
02
Drugs
ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20220216054042N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220216054042N1.